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Progressive elimination of rabies in wildlife has been a 
general strategy in Canada and the United States; common 
campaign tactics are trap–vaccinate–release (TVR), point 
infection control (PIC), and oral rabies vaccination (ORV). 
TVR and PIC are labor intensive and the most expensive 
tactics per unit area (≈$616/km2 [in 2008 Can$, converted 
from the reported $450/km2 in 1991 Can$] and ≈$612/km2 
[$500/km2 in 1999 Can$], respectively), but these tactics 
have proven crucial to elimination of raccoon rabies in Can-
ada and to maintenance of ORV zones for preventing the 
spread of raccoon rabies in the United States. Economic as-
sessments have shown that during rabies epizootics, costs 
of human postexposure prophylaxis, pet vaccination, public 
health, and animal control spike. Modeling studies, involv-
ing diverse assumptions, have shown that ORV programs 
can be cost-efficient and yield benefit:cost ratios >1.0.
Rabies continues to pose major public health concerns in Canada and the United States (1–5). Effective pet vac-
cination programs have controlled rabies in domestic dogs 
(Canis familiaris) in both countries, but rabies persists in 
wildlife reservoirs. In 2007, a total of 6,776 cases in wild-
life were reported for the contiguous United States (1).
Oral rabies vaccination (ORV) is an evolving rabies 
control technology for use in wildlife (6). It involves dis-
tribution of baits containing orally immunogenic vaccines 
onto the landscape, thereby targeting wildlife to establish 
population immunity and prevent spread or eliminate spe-
cific rabies variants (6).
We reviewed the literature on ORV programs and 
economics in Canada and the United States. The first use 
of ORV sought to control rabies in red foxes (Vulpes vul-
pes) in Switzerland; subsequent programs were reported 
throughout much of western Europe (7,8). Switzerland, 
France, Belgium, and Luxembourg were deemed free of 
the red fox variant by 2001 (8).
ORV in Ontario, Canada
Arctic Fox–Variant Rabies in Red Foxes
During 1989–1995, ORV was used in Ontario to pro-
gressively eliminate arctic fox (Alopex lagopus)–variant 
rabies that had spilled into (i.e., had been transmitted to 
another species) red foxes and spread southward (9). Each 
year ORV baits were distributed in southern Ontario (≈20 
baits/km2, from aircraft or by hand, over 8,850–29,590 
km2). The strategy was termed progressive elimination and 
resembled an expanding ORV wedge, which started near 
the center of the outbreak and expanded during successive 
years (Figure 1).
Within 5 years of program initiation, reported cases of 
rabid foxes declined from 203 cases/year to 4 cases/year in 
the baited areas (9,10). Spillover cases from red foxes to 
striped skunks (Mephitis mephitis) and livestock dropped 
from preepizootic (30-year) means of >36 and >42, respec-
tively, to 0 by 1997 (9). Since 2003, only 13 cases of the 
variant in red foxes have been reported; these continue to 
be addressed by using focused control and enhanced sur-
veillance (i.e., increased public health monitoring, exami-
nation of road-killed target animals, and rabies analyses of 
samples from trappers) (D. Donovan, Ontario Ministry of 
Natural Resources, pers. comm.).
Rabies in Raccoons and Skunks
During 1987–1991, to reduce spillover of rabies from 
red foxes to urban raccoons (Procyon lotor) and skunks, 
trap–vaccinate–release (TVR; capture live, vaccinate par-
enterally, and release on site) was integrated into ORV 
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campaigns in the Toronto area (10). TVR was part of 
the red fox ORV program because Evelyn-Rokitnicki-
Abelseth oral rabies vaccine is not immunogenic in skunks 
and raccoons (6,9). Live traps were set (20–75 traps/km2) 
in a 60-km2 portion of the city, and 66,168 ORV baits were 
distributed by hand in natural areas (20–40 baits/km2). Of 
sampled foxes, 46%–80% had biomarkers from baits, and 
only 1 rabid fox was found during 1987–1992 (10). A re-
cent update of ORV baiting in Toronto stated that 332,257 
baits had been distributed during 1989–1999, and only 5 
rabid foxes were found during 1990–2006 (11).
During 1999–2000, the raccoon variant of rabies was 
confirmed near Brockville, Ontario (12). To eliminate 
raccoon-variant rabies from the province, a point infection 
control (PIC) tactic, which integrated population reduction 
(PR; sometimes referred to as culling or depopulation), 
TVR, and ORV, was implemented (12). The initial PIC op-
eration included concentric zones, each consisting of 1) an 
inner 5-km PR zone, 2) a middle 5-km TVR zone, and 3) 
an outer 8–15-km ORV zone (Figure 2). Additional PIC or 
modified PIC (no PR) operations were centered on newly 
discovered rabid raccoons (≈40).
Mean raccoon densities in PR zones dropped from 
5.1–7.1/km2 before to 0.6–1.1/km2 after PIC operations. 
However, within 1 year, >37 more cases of raccoon-vari-
ant rabies occurred in the PIC regions (12). Intensive PIC 
was begun again and eliminated the variant from Ontario. 
Subsequently, to reduce the chances of raccoon-variant 
rabies recurring in southern Ontario, enhanced surveil-
lance and annual ORV was conducted along the border 
of Ontario and New York (D. Donovan, pers. comm.). 
Elimination of raccoon rabies from Wolfe Island at the 
mouth of the St. Lawrence River using similar tactics was 
recently reported (13).
ORV in the United States
Canine-Variant Rabies in Coyotes in Southern Texas
 During 1988–1994, a canine-variant of rabies de-
scribed in Mexico was confirmed in 163 domestic dogs and 
296 coyotes from 18 counties in southern Texas (14–16). In 
1995, to prevent the northward spread of this variant, ORV 
baits (9–27 baits/km2) were distributed in an arc-shaped 
band over a 24-county area (39,850 km2) ≈200 km north 
of Laredo (16). During 1996–2003, annual baiting contin-
ued; ≈9.35 million baits were distributed onto ≈741,766 
km2 (17). Gradually, baits were distributed farther south, 
toward the Rio Grande River, in subsequent years, thereby 
collapsing the rabies-infected area (Figure 3). To protect 
livestock, coyotes were also removed from portions of the 
ORV zone during these years, but the effect of PR relative 
to ORV was not assessed (18,19). PR is considered an im-
portant component of many rabies-control models (20).
After 1 year of baiting, the mean rate of canine-vari-
ant cases at the leading edge of the epizootic area was 
2.8/10,000 km2. This rate was similar to that of the preepi-
zootic period and suggestive that the northward spread of 
the epizootic had ceased (16). Subsequent surveillance 
showed a gradual decline in cases from 122 in 1995 to 0 
in 2004 (17). Currently, to maintain an immune buffer and 
prevent canine rabies from reemerging in southern Texas, 
this program baits an ORV zone 30–65 km wide along the 
international border each year (E. Oertli, Texas Department 
of State Health Services, pers. comm.).
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Figure 1. Expanding-wedge tactic with progressive elimination 
(9). Numbers represent successive oral rabies vaccination (ORV) 
zones. Potential savings are assumed for the area of progressive 
elimination, southern Ontario Province. The rectangle bordering the 
rabies source (i.e., 5) highlights an area of enhanced surveillance, 
possible point infection control (PIC) activities, trap–vaccinate–
release (TVR) activities, or an ORV zone intended to deter future 
reemergence of the virus. 
Figure 2. Point infection control (PIC) tactic. Concentric rings 
around the location of a rabid animal represent vector population 
reduction (PR), trap–vaccinate–release (TVR), and ORV zones 
(12). Each new source leads to repeated, overlapping ORV, TVR, 
and PR rings. Potential savings are assumed within the zones and 
for assumed distances beyond the zones. 
TVR
PR?
1st?rabies?
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ORV
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Gray Fox–Variant Rabies in West-Central Texas
During 1988–1994, a total of 283 gray foxes (Uro-
cyon cinereoargenteus) and 241 other domestic and wild 
animals in west-central Texas were confirmed positive for 
a unique rabies variant typically found in gray foxes (17). 
This outbreak was spatially distinct from the outbreak of 
canine rabies in southern Texas. To control this epizootic, 
during 1995–2009 (and ongoing), ORV (29–39 baits/km2) 
was conducted annually by encircling the epizootic area 
using ≈32-km–wide ORV strips; an added 16- to 24-km 
vaccination buffer of ORV baits was created along the 
northern and eastern edges of the rabies-variant area; this 
tactic has been referred to as a purse string–like tactic (i.e., 
encircle and shrink) (17; Figure 4). An area of ≈350,000 
km2 was baited annually. Evidence of bait biomarkers 
and positive rabies virus neutralizing antibody titers was 
found for 39% and 62% of foxes, respectively, sampled 
from the ORV zone, confirming that numerous foxes had 
been vaccinated.
In 2007, new cases of gray fox rabies occurred north-
westward along the Pecos River and in west-central Texas. 
To prevent further spread of this variant, ORV was used 
(E. Oertli, pers. comm.). The rabies-control goal has not 
changed from one of containment and elimination of the 
gray fox variant from Texas. However, in light of recent 
surveillance, the anticipated strategy of establishing and 
maintaining an ORV zone along the Rio Grande River to 
prevent potential reemergence from Mexico has been de-
layed and is being refined to include prolonged enhanced 
surveillance as a key factor in allocating resources and 
gauging success (E. Oertli, pers. comm.).
Raccoon-Variant Rabies in the Eastern United States
The National Rabies Management Program began in 
1997 and coordinates ORV and related wildlife rabies–
control activities in the United States (21,22). One of its 
priorities is to prevent the spread of raccoon-variant rabies 
into uninfected areas, particularly west of its current distri-
bution along the Appalachian Ridge (22). The Program in-
tegrates natural terrain features (e.g., rivers, lakes, and poor 
habitat along mountain ridges) with ORV zones (baited at 
50–75 baits/km2) to create a 40–50 km zone of vaccinated 
raccoons to help prevent the spread of the virus (Figure 5).
During 1997–2007, the ORV zone was expanded from 
parts of Ohio to encompass parts of 8 states (i.e., Ohio, 
Pennsylvania, West Virginia, Virginia, Tennessee, North 
Carolina, Georgia, and Alabama) along the Appalachian 
Ridge. A total of 58 bait distributions (usually 1/year) total-
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Figure 3. Collapsed-bands tactic with progressive elimination (17). 
Numbers represent successive oral rabies vaccination (ORV) 
zones that attempt to collapse the baited area, exclude virus 
incursion outside, and lead to a maintenance zone that prevents 
reintroduction of the disease after the current population matures 
and vaccination effects are lost. Potential savings are assumed to 
occur within the ORV areas and for assumed distances beyond the 
zone. The rectangle bordering the rabies source (i.e., 5) high-lights 
an area of enhanced surveillance, possible point infection control 
(PIC) activities, trap–vaccinate–release (TVR) activities, or an ORV 
zone intended to deter future reemergence of the virus. 
Figure 4. Purse string–like tactic with progressive elimination (17). 
Numbers represent successive oral rabies vaccination (ORV) zones 
that attempt to roughly encircle and shrink the baited area, exclude 
virus incursion from outside, and lead to a maintenance zone that 
prevents reintroduction of the disease after the current population 
matures and vaccination effects are lost. Potential savings are 
assumed to occur within the ORV areas and for assumed distances 
beyond the outer zone. The rectangle bordering the rabies source 
(i.e., 5) highlights an area of enhanced surveillance, possible point 
infection control (PIC)/trap–vaccinate–release (TVR) activities, or 
an ORV zone intended to deter future reemergence of the virus.
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ing ≈41,018,800 baits and covering ≈530,825 km2 (range of 
28,660 km2 to 84,225 km2/distribution) have characterized 
this effort as of 2007 (R. Hale, US Department of Agricul-
ture, pers. comm.). On the basis of rates of spread of 30–60 
km/year in the Mid-Atlantic states before 1997 (22–24), 
ORV is viewed as having slowed movement of the virus 
and, with contingency actions to eliminate some dispersed 
cases, prevented westward spread of rabies among rac-
coons. Relatively low and variable vaccination rates have 
been found, despite the use of relatively high bait densities 
(50–100/km2). Estimated raccoon vaccination rates, based 
solely on the index of rabies virus neutralizing antibody re-
sponse, range from 10% to 55% (22). The need to vaccinate 
annually is dictated mainly by high death rates for juveniles 
and a relatively young age structure for raccoons in North 
America; juveniles often account for 50% of raccoon popu-
lations (22). Still, enhanced and public health surveillance 
indicate that areas west of the Appalachian Ridge remain 
free of raccoon-variant rabies (1,22,23).
To maintain the integrity of the Appalachian Ridge 
ORV zone, contingency actions have been needed. In 2004, 
emergency ORV baiting and TVR were used in northeast 
Ohio between the established ORV zone and the eastern 
suburbs of Cleveland (25). TVR of >300 raccoons and mul-
tiple ORV distributions occurred in this contingency ac-
tion. This ORV zone had been widened earlier because of 
encroachment of rabid raccoons from Pennsylvania (26).
Other contingency actions unrelated to the westward 
spread of raccoon rabies have also been implemented. In 
2004, an ORV zone created near the Cape Cod Canal to pre-
vent spread of raccoon-variant rabies onto Cape Cod, Mas-
sachusetts, was breached, and raccoon-variant rabies spread 
rapidly throughout the peninsula (T. Algeo, US Department 
of Agriculture, pers. comm.). Currently, ORV is used twice 
a year (spring and fall) in the eastern half of the Cape, and 
baiting is moved gradually westward until an ORV zone 
can be reestablished along the Cape Cod Canal (J.C. Mar-
tin, Tufts Cummings School of Veterinary Medicine, pers. 
comm.). Additionally, to prevent raccoon rabies from re-
emerging in southern Ontario, ORV baiting for raccoon-
variant rabies continues in northern New York. Confirmed 
positive raccoon-variant cases in southern Quebec have led 
to extensive PIC and ORV campaigns to prevent the disease 
from reaching Montreal. Together, these events and con-
tingency actions illustrate the challenges posed by raccoon 
rabies, the importance of enhanced surveillance, plus the 
need to anticipate unexpected contingency actions and their 
related costs as a component of ORV campaigns.
Rabies-related Costs
Several studies have documented the costs associ-
ated with wildlife-rabies epizootics (27–31; see online 
Technical Appendix 1, available from www.cdc.gov/EID/
content/15/8/1176-Techapp1.pdf). Costs have been ad-
justed for inflation to 2008 US$ or Can$. A raccoon-vari-
ant rabies epizootic in the early 1990s in Hunterdon and 
Warren Counties, New Jersey, more than doubled rabies-
related control costs from $6.67/county resident at $591/
km2 ($4.05/county resident and $359/km2, US$ in 1990) to 
$16.13/county resident at $1,503/km2 ($9.79/county resi-
dent at $913/km2, US$ in 1990) (27).
In Massachusetts, a multiyear study found that the me-
dian cost of postexposure prophylaxis (PEP) was $3,356/
patient ($2,376/patient; range $1,038–$4,447, US$ in 
1995); 69% of the cost was for biologics (28). Numbers of 
PEP administrations increased 26-fold, from 1.7/100,000 
residents in 1991 to 45/100,000 residents in 1995 (28). Es-
timates for Connecticut were similar (29).
A raccoon-variant epizootic in New York State be-
gan in 1991, and the resultant rate of PEP administrations 
ranged from the equivalent of 24 to 34/100,000 residents 
(no preepizootic estimates of PEP given) (30). During 
1998–1999, the mean PEP cost was $1,501/person treated 
($1,136/person, US$ in 1998; biologics and administra-
tion), equivalent to between $36,024 and $51,034/100,000 
residents ($27,264 and $38,624/100,000, US$ in 1998); 
New York City’s population is excluded from these esti-
mates. This lower cost compared with that for Massachu-
setts (28) and Connecticut (29) may be the result of local 
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Figure 5. Oral rabies vaccination (ORV) preventive spread or 
elimination tactic with eventual progressive elimination (22). The 
ORV zone of vaccinated animals is intended to prevent spread of 
the disease beyond the ORV zone; potential elimination is assumed 
to result from successive baiting campaigns into the infected area. 
Potential savings are assumed beyond the ORV zone (or within the 
zone, if elimination is possible); disease spread rates, final distances 
of infectious impacts, and durations of ORV bait distributions 
ultimately determine the magnitude of potential savings. PIC, point 
infection control activities; TVR, trap–vaccinate–release activities.
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public health department coordination of PEP administra-
tions in New York State (30).
Recently (1998–2002), rabies exposure costs were es-
timated at $4,066/patient ($3,688/patient, US$ in 2005) in 
southern California (31). Average direct (biologics, medi-
cal costs) and indirect costs (travel to physicians, day care 
for medical appointments) were estimated at $2,827/pa-
tient and $1,239/patient, respectively ($2,564/patient and 
$1,124/patient, US$ in 2005).
ORV Program Costs
Bait costs and detailed descriptions of the areas baited, 
which allowed computations of unit area expenses, are avail-
able in Table 1 and online Technical Appendix 2 (available 
from www.cdc.gov/EID/content/15/8/1176-Techapp2.pdf). 
ORV programs in Canada and the United States have lasted 
from >1 for some to >11 years for others and have often 
required integration of contingency actions (Table 1). The 
most expensive tactics have been labor-intensive PIC and 
TVR, but their effectiveness is crucial to maintaining the 
overall integrity of certain ORV campaigns (10–13,22,25). 
PIC programs have been reported to cost $612/km2 ($500/
km2, Can$ in 1999); costs reported for 3 PIC operations 
for raccoons totaled $469,247 ($363,100, Can$ in 1999; 
12). TVR costs have ranged from $616/km2 to $1,573/km2 
($450/km2 to $1,150/km2, Can$ in 1991; Table 1).
The target species of ORV greatly affects costs, 
mainly because of species-specific, bait-density require-
ments. Bait densities for foxes and coyotes have been less 
than half those for raccoons (Table 1). Thus, gray fox and 
coyote ORV programs in Texas averaged $48/km2 ($42/
km2, US$ in 2004; Table 1), and raccoon programs in the 
eastern United States averaged between $111/km2 ($108/
km2, US$ in 2007) and $198/km2 ($153/km2, US$ in 1999). 
Cumulative cost of the Appalachian Ridge ORV program 
has totaled ≈$57 million since its inception in 1997; baits 
accounted for 72% of the funds expended (Tables 1, 2).
Annual costs vary as changes in ORV zones occur, 
as contingency actions occur, and as ORV programs shift 
from preventing spread to eliminating variants in given 
geographic areas. Individual bait prices in the United States 
range from $1.00 to $1.25 (US$ in 2008, depending on bait 
type). Because of improved production efficiency, bait 
prices have decreased slightly during the past 5 years.
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Table 1. Major oral rabies vaccination campaigns, Canada and the United States*  
Country and 
reference Strategy or tactic 
Duration,
y
Target
species Unit bait cost
Target bait 
density, 
no./km2
ORV, TVR, or 
PIC area, km2/y† Cost/km2‡
Canada
 (9) ORV progressive 
elimination
>7§ Red fox Not reported 18–20 8,850–31,460 No estimate 
 (10) TVR 5§ Skunk,
raccoon,
red fox 
>$2.00
(Can$ 1991) 
20/den
fox only 
60 $450–$1,150 
(Can$ in 1991) 
 (12) PIC >1§ Raccoon >$2.00
(Can$) 
70 225 PR, 485 
TVR, 1,200 ORV 
$500
(Can$ in 1999) 
United States§ 
 D. Slate, unpub. 
 data (2007) 
ORV zone 
(Appalachian Ridge) 
>1§ Raccoon $1.22 (US$) 50–75 28,659–84,225 $108
(US$ in 2007) 
 (26) ORV zone (Ohio–
Pennsylvania border) 
4§ Raccoon $1.37–$1.52
(US$)
75 3,872–6,497 $153; range 
$102–$262
(US$ in 1999)¶ 
 (17) ORV progressive 
elimination
>9§ Coyote Not reported 19–27 38,850 $42
(US$ in 2004)# 
 (17)  ORV progressive 
elimination
>8§ Gray fox Not reported 27–39 56,202 $42
(US$ in 2004)# 
*Unless otherwise noted, costs are in Can$ or US$. No discounting for inflation was used; this article and online Technical Appendix 2 
(www.cdc.gov/EID/content/15/8/1176-Techapp2.pdf) provide inflation-corrected costs in 2008 Can$ or US$.  
†Components of reported areas differ according to tactic and strategy. Oral rabies vaccination (ORV) entails topographic areas at which baits are 
distributed at target densities over landscape. Trap–vaccinate–release (TVR) involves relatively limited topographic areas of intense live trapping and 
parenteral vaccination of captured animals. Point infection control (PIC) involves successive concentric rings of population reduction, TVR and ORV; the 
concentric rings become distorted if subsequent rabid animals are caught within these rings. New concentric rings are now formed according to these 
occurrences. Additionally, depending on habitat or location of urban centers, ORV may be used in a larger strip to create an added ORV preventive zone. 
‡Most cost estimates include purchase of baits, aircraft, fuel, and equipment but often omit accurate labor charges.  
§Surveillance, TVR, PIC, or ORV bait distributions continue at present; therefore, current duration and areas baited differ from those reported. According 
to Foroutan et al. (26), ORV baitings continue as part of the National ORV Program (Slate et al. [22]).  
¶According to Foroutan et al. (26), areas were baited twice each year. In 1997, the first baiting was conducted over a smaller area (1,780 km2), and in 
May 1997 (initial) and June 1999, 2 smaller emergency baitings (in response to a breach in the ORV zone) were conducted, covering <1,701 km2.
Average costs include a baiting in April 1999, when several tests of bait densities (high) were conducted.  
#According to Sidwa et al. (17), the area baited had shrunk over time because of progressive coyote-variant rabies elimination, but the purse string (gray 
fox) tactic and ORV-baited area were expanded in 2007 as the gray fox variant spread north along the Pecos River and into southern Texas. The area 
cost estimate was derived as the quotient of a reported $3.8 million/year program cost and average annual 33,669 km2 (dog and coyote) and 56,202 km2
(gray fox) bait zones (sum 89,871 km2) cited in online Technical Appendix 2.  
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Potential ORV-Induced Savings
One ex post study (actual returns, after the fact) pro-
vided detailed estimates of PEP administrations in Ontario 
during 1956–2000 (32). Annual PEP administrations in-
creased from ≈1,000/year during the 1960s and 1970s to 
>2,000/year during 1982–1993, then decreased to ≈1,000/
year again after large-scale ORV campaigns targeting red 
foxes began in 1989 (9,10,32). Many factors could account 
for these changes, including revisions of PEP administra-
tion guidelines. The initial increase in PEP administrations 
possibly occurred as a result of fewer adverse effects from 
use of the new human diploid cell vaccine and stability in 
numbers of rabies cases (32). The latter decrease in PEP ad-
ministrations was coincident with ORV-caused elimination 
of arctic fox–variant rabies from southern Ontario (9).
Modeling the Benefits and Costs of ORV
Measured costs of an epizootic of raccoon rabies in 
New Jersey were used to model the costs and benefits of a 
hypothetical ORV program (27). The model projected net 
savings for ORV (Table 3) based on the assumptions that 
the ORV program would require a 2-year campaign and 
that expenditures to protect human health would remain 
constant. The model did not allow for reintroduction of ra-
bies or for the potential reemergence of rabies. Benefit:cost 
ratios (BCRs) related to this hypothetical use of ORV were 
reported as >2.2 (27; online Technical Appendix 3, avail-
able from www.cdc.gov/EID/content/15/8/1176-Techapp3.
pdf) summarizes key principles of benefit:cost modeling).
Use of ORV to eliminate raccoon rabies from a hy-
pothetical area of 34,447 km2 was modeled under 2 sce-
narios (33). Scenario 1 assumed that concentric ORV zones 
(rings) would expand outward from a center over a 20-year 
period and that the ORV zone would be maintained for 10 
more years to prevent reintroduction. Scenario 2 assumed 
that the entire area would be baited in the first 2 years and 
that a ring-shaped ORV zone would be maintained for 28 
more years. In the first scenario, inclusion of an expected 
20% increase in pet vaccinations (27) as a benefit resulted 
in $3.1 million net savings from ORV; removing pet vac-
cinations as a savings yielded a net cost of $7.7 million 
($6.2 million, US$ in 2000; Table 3). The second scenario 
yielded no net savings unless the cost of maintaining a con-
tainment zone was removed from the model (33).
The economics of a large-scale ORV program to pre-
vent the westward spread of raccoon-variant rabies in the 
eastern United States was modeled and used in planning 
the current Appalachian Ridge program (34). Scenarios 
assumed that a raccoon-variant rabies epizootic would ad-
vance in 40 or 127 km/year (fixed rates) bands to the west 
of the current leading edge of raccoon-variant rabies along 
the Appalachian Ridge (22). Input variables were as fol-
lows: 7% discount rate, 102,650 km2 ORV zone, 75 baits/
km2, $1.63/bait ($1.30/bait, US$ in 2005), $10.78/km2 
($8.62/km2, US$ in 2000) aerial distribution, and $18.75/
km2 ($15.00/km2, US$ in 2000) post-ORV evaluation. The 
effect of an epizootic was calculated in terms of unit human 
population within bands. Results showed that all 8 scenar-
ios, except the 40 km/year spread rate with 20-year fixed 
baiting costs, yielded BCRs >1.1 and that total estimated 
net present values of the program were $48–496 million 
with >$96 million in discounted program costs (34). Be-
cause of natural geographic features, raccoon population 
dynamics, and other factors that affect the spatial and tem-
poral spread of rabies, an assumed variable spread of the vi-
rus westward would have been more realistic (25,26). As in 
previous models (27,33), estimates of net savings (>50%) 
for scenarios were enhanced by inclusion of potential pet 
vaccination costs.
Another model examined specific costs of baiting 
campaigns for raccoon rabies along the Ohio–Pennsylvania 
border (26). This model incorporated movement and life-
cycle data for rabid and nonrabid raccoons. An area of 400 
km2 with a 10-km ORV zone was assumed to be baited. 
Benefits were predicted to accrue mainly in a 5-km strip 
on the west side of the ORV zone. Assumptions about rac-
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Table 2. Approximate, undiscounted total costs of largest oral rabies vaccine programs, North America, 1989–2004* 
Location, target species Years 
Total undiscounted 
costs, million $ 
Average undiscounted 
annual costs, million US$ Reference
Ontario, red foxes 1989–2000 Can$43† 3.5 S.A. Shwiff, unpub. data* 
Texas, coyotes and gray foxes 1995–2003 US$34 3.8 (17)‡
Appalachian Ridge, raccoons 1997–2007 US$57 5.2 D. Slate, unpub. data§ 
*Costs are estimates in Can$ or US$ as reported in original publication or as cited by unpublished source.  
†S.A. Shwiff et al. (unpub. data) based their calculations on certain data presented in 9,32.
‡Sidwa et al. (17) stated that (for both programs combined) average annual costs were $3.8 million. We computed this value as follows: 9 years × $3.8 
million = $34 million total (i.e., Sidwa et al. did not clarify what was included in their cost estimate).  
§D. Slate (2007, unpub. data) provided air, bait, fuel, and staff costs, although some staff hours and fuel costs were omitted for initial campaigns during 
1997–2001; a total of 9,394 staff hours, $5,868,262 aircraft costs, $923,481 fuel costs, and $50,187,380 bait costs were reported for 58 campaigns 
involving the dispensing of 41,018,811 baits over 530,825 km2. The software used to determine bait distribution costs was prepared by staff of the United 
States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Rabies Management Program. After deselecting 
the bait zones, flight lines were drawn by using the topography (e.g., avoiding water and residential areas) to determine the flight lines and transects. After 
that had been established, the bait zones were populated with the lines and measured to determine the total length (km). Flight lines determine total flight 
hours: ([km × 0.539958 nautical miles]/flight speed [knots] = flight hours). Fuel usage is computed as follows: (flight hours × consumption rate [91 
gallons/h] × fuel price/gallon = total fuel cost). Costs were also influenced by air transect width, distance to airports for refueling, and end-of-transect 
turning distance.  
SYNOPSIS
coon carrying capacity and percentage ORV vaccination 
efficiency influenced the rate of rabies spread. This model 
predicted a net cost for ORV; however, a simple extrapola-
tion implied that net savings would have occurred if the 
benefits were projected for a 100-km strip west of the ORV 
zone (26).
Ex post modeling was conducted for the ORV cam-
paigns that eliminated red fox–vectored rabies in Ontario. 
Estimated ORV benefits (PEP + animal rabies tests + live-
stock indemnity) ranged from $35.4 million to $99.3 mil-
lion ($35 million to $98 million, Can$ in 2007; total pro-
gram costs were $78.0 million ($77 million, Can$ in 2007) 
(S.A. Shwiff, unpub. data). BCRs ranged from 0.49 to 1.36, 
and outputs implied a lag effect for savings; BCRs were 
<1.0 during 1990–1992 and >1.0 during 1993–2000.
Recently, an ex post modeling analysis was performed 
for the 1995–2006 ORV program that eliminated canine-
variant rabies from southern Texas (16,17,35). Total expen-
1182 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 8, August 2009
Table 3. Comparison of selected modeling studies that examined the economics of oral rabies vaccination programs* 
Reference
Locale, tactics, 
target species
Type of study, 
model
Duration
modeled,
y
Cost and density of 
vaccine baits; 
distribution costs† Results Comments
(27) 2 counties in 
New Jersey, 
ORV, raccoon 
Benefit:cost, cost 
data collected from 
field with 
hypothetical baiting 
program
5 $1–$2/bait; 62–200 
baits/km2;
distribution
$100/km2
Net savings $13.34–
$20.78/ county 
resident (1990 US$); 
$1,244/km2 – 
$1,939/km2
Probably unrealistic: 
assumed only 2 
baitings; no 
contingency costs; 
main economic 
benefit = reduced pet 
vaccinations
(33)‡ Hypothetical 
34,447 km2-
area, expanding 
circle then 
maintained
barrier zone, 
raccoon
Benefit:cost of 
hypothetical baiting 
program, extensive 
sensitivity analyses 
30 $1.50/ bait; 100 
baits/km2 (range 
40–115);
distribution $39/km2
(maximim $100/ 
km2)
Net savings of $3.1 
million if reduced pet 
vaccinations included 
as benefit. Net cost 
($6.2 million) if pet 
vaccinations
excluded.
Lack of data required 
many assumptions; 
bait density, cost/ 
bait, and value of pet 
vaccinations were the 
most critical elements
(34)§¶ Appalachian
Ridge area, 
ORV, raccoon 
Benefit:cost model 
of program to deter 
westward spread of 
raccoon rabies 
20 $1.30/bait, 75 
baits/km2 ; aerial 
distribution $8.62/ 
km2; evaluation 
$15/km2
Net savings $100–
$500 million (2000 
US$)
Assumed that without 
ORV, rabies would 
move 42 or 125 km/y 
west; distribution 
costs are low; animal 
vaccinations are 
critical component 
(26)# Ohio–
Pennsylvania, 
ORV zone (400 
km2), raccoon 
Simulation of 
individual raccoons 
+ benefit:cost model 
to prevent westward 
spread of raccoon 
rabies
40 $1.47/bait; 3 
scenarios of 70, 
100, 175 baits/km2.
Distribution
$23.23/km2
Net costs (1999 US$; 
savings recouped 5 
km band west of 
zone)
Complex model 
showing importance 
of many biological 
factors determining 
potential for success 
and net savings 
(35) Texas, 
progressive
elimination,
collapsed bands, 
coyote 
Retrospective
benefit:cost
model; projected 
population-based 
PEP and animal 
test costs for 20 
southern to 232- 
county expansion 
area
12 $26.3 million total 
cost (2006 US$; 
Texas Department 
of State Health 
Services
accumulated value) 
Net savings $98–
$354 million; BCRs of 
3.7–13.4; range of 
savings for 100%, 
50% and 25% of PEP 
and rabies tests in 
epizootic area. 
Simple model 
showing wide-area 
expansion. ORV 
proved cost-efficient 
if projections were 
reduced to 7% of the 
PEP and tests for 
epizootic counties 
S.A. Shwiff, 
unpub. data 
Ontario, 
progressive
elimination,
expanded 
wedge, arctic-
fox variant, 
red fox 
Benefit:cost
measured costs but 
had to model 
savings
12 $77.4 million (2006 
Can$) for total ORV
Net savings in 3 of 4 
scenarios: reductions 
in animal rabies 
testing accounted for 
most net savings. 
Assumed multiple 
estimates of future 
rabies-related costs 
*No inflation corrections used. ORV, oral rabies vaccination; PEP, postexposure prophylaxis; BCRs, benefit:cost ratios. 
†Distribution costs exclude cost of bait purchases. US$ except as indicated. 
‡For example, Meltzer (33) posited a baseline assumption with a distribution cost of $39/km2.
§Kemere et al. (34) assumed that the “… effectiveness of vaccination programs would be validated through surveillance and testing of raccoon 
populations in the ORV zones … [evaluation cost] also includes educational, promotional, and overhead expenses.” 
¶Although Kemere et al. (34) did not explicitly allow for contingency costs (to allow for breaches of ORV zones, etc.), they did sensitivity analyses 
assuming “… the full program costs are used for the entire period instead of dropping to 40% after 5 years.” 
#Foroutan et al. (26) only considered benefits extending up to 5 km west of the ORV zone. A simple extrapolation would suggest that net savings would
occur if the calculated benefits were to extend some 100–150 km west of the ORV zone. 
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ditures for the ORV program were compared with benefits 
accrued from likely PEP administrations and animal rabies 
tests estimated for the 20-county epizootic area and project-
ed to an area involving most of the state. Estimated benefits 
ranged from $95 million to $369 million ($89 million to 
$346 million, US$ in 2006); total ORV program costs were 
reported as $28 million ($26,358,221 US$ in 1995–2006). 
BCRs ranged from 3.4 to 13.1, depending on assumed in-
cidence of PEP administrations and animal tests (35). This 
study confirmed that 56/100,000 residents received PEP 
during the epizootic, a high rate for the sparsely populated 
area of southern Texas where the disease occurred (35).
Conclusions
ORV of wildlife has had positive public health effects. 
Multiyear campaigns have led to progressive elimination of 
arctic fox–variant and canine-variant rabies in Ontario and 
Texas, respectively. PIC, TVR, and ORV zones have pre-
vented raccoon-variant rabies from becoming established 
in Ontario. Campaigns to contain and eliminate rabies in 
gray foxes of west-central Texas continue, and spillover of 
gray fox–variant rabies into coyotes may pose new chal-
lenges for preventing the spread of this variant. The ORV 
zones and contingency actions along the Appalachian 
Ridge have, thus far, prevented westward spread of rac-
coon rabies. Habitat alterations to reduce potential carrying 
capacities of raccoons through local no-feeding regulations 
and improved refuse management would aid rabies control 
efforts, but these measures are difficult to implement and 
enforce. Improved bait-vaccine technology, potentially in-
tegrating reproductive inhibitors into TVR campaigns for 
specific urban raccoon and skunk populations, may im-
prove wildlife rabies elimination.
Rabies campaigns have been relatively expensive. We 
estimate that >$130 million (combined Can$ and US$) has 
been spent on ORV programs in North America during the 
past 10 years. Programs have proved lengthy (typically >5 
years), have required enhanced surveillance, and have of-
ten required contingency actions to ensure rabies elimina-
tion without reintroduction.
Most economic assessments and modeling studies in-
dicate that ORV programs can yield cost savings (32–35). 
Regional increases in PEP administrations (and associated 
public health costs) from 2–4/100,000 before to 24/100,000 
(30), 45/100,000 (28), or 66/100,000 (27) residents during 
or after have been documented for nonbat rabies epizoot-
ics. Reduced PEP, epizootic-related pet vaccinations, ani-
mal diagnostic tests, public education activities, and other 
factors represent costs avoided by ORV programs. Direct 
estimates of wild mammal populations and the relationship 
of these to numbers of PEP administrations are difficult to 
obtain; this topic was beyond the scope of our review but 
needs research.
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etymologia
Lyssavirus
[lis′ə-vi′′rəs]
From the Greek lyssa (frenzy or madness) and Latin virus (poison). In Greek mythology, Lyssa was the goddess of 
rage, fury, and rabies, known for driving mad the dogs of the hunter Acteon and causing them to kill their master. 
Aristotle (4th century bce) said, “Dogs suffer from the madness. This causes them to become irritable and all 
animals they bite to become diseased.” The disease in humans was characterized by hydrophobia, in which the sick 
person was simultaneously tormented with thirst and with fear of water. Hippocrates is believed to refer to rabies 
when he said that persons in a frenzy drink very little, are disturbed and frightened, tremble at the least noise, or 
are seized with convulsions.
Lyssavirus is a genus of the family Rhabdoviridae, which includes rabies virus and other related viruses that infect 
mammals and arthropods (e.g., Australian bat lyssavirus, Duvenhage virus, European bat lyssaviruses 1 and 2, 
Lagos bat virus). 
Source:  Steele JH, Fernandez PJ. History of rabies and global aspects. In: Baer GM. The natural history of rabies, 2nd ed. New 
York; CRC Press; 1991. Philadelphia: Saunders; 2007; Mahy B. The dictionary of virology, 4th edition. London: Academic Press; 
2009. Dorland’s illustrated medical dictionary, 31st edition.
  
Tactics and Economics of  
Wildlife Oral Rabies Vaccination,  
Canada and the United States 
Technical Appendix 1 
Wildlife Rabies-related Costs (Details of Published Studies;  
No Inflation Corrections Used) 
A cost-comparison study examined expenditures for controlling rabies before (1988) and 
during (1990) a raccoon-variant rabies epizootic in Hunterdon and Warren counties, New Jersey, 
USA (1). This study examined perhaps the most diverse set of costs thus far reported, but these 
entailed relatively short-term, small-area estimates. The epizootic more than doubled rabies-
related control costs, from $4.05 ($359/km2) to $9.79/county resident ($913/km2, 1990 US$). 
Both before and during the epizootic, pet vaccinations were the largest single cost component of 
rabies expenses; the costs for vaccinations of domestic animals were $337,998/100,000 residents 
in 1988 and $640,552/100,000 residents in 1990. The next largest category was “other rabies 
control activities” (e.g., public health, public education) accounting for 11% of costs in 1988 and 
13% in 1990. The number of persons receiving postexposure prophylaxis (PEP) increased from 2 
in 1988 (1/100,000 residents) to 131 in 1990 (66/100,000 residents). Although the average cost 
was $555/person treated in 1988 and $1,138/person in 1990, PEPs only accounted for 8% of the 
rabies-related costs at the peak of the epizootic in New Jersey in 1999. 
In Massachusetts, a multiyear study focused on the increased use and cost of PEP during 
1991 (1 year before a rabies epizootic) and from 1992 through 1995 of a raccoon rabies epizootic 
in the state (2). The median cost of PEP was $2,376/person (range: $1,038–$4,447; 1995 US$); 
69% of the cost was due to biologics. Estimates were similar for Connecticut (3). Numbers of 
PEP administrations increased from 1.7/100,000 residents in 1991 to 45/100,000 residents in 
1995 (26-fold increase). Thus, this rabies epizootic increased PEP-related costs by 
$102,880/100,000 residents. 
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During the 1990s, New York State reported an epizootic of raccoon-variant rabies (4). 
The number of PEPs given in the state during the epizootic ranged from 2,422 in 1995 to a high 
of 3,373 in 1997 (no preepizootic numbers reported; New York City (NYC) is excluded from 
this statewide public health study). These are roughly equivalent to 24 and 34 PEPS per 100,000 
residents (calculated using 2000 census count of 10 million state residents, excluding NYC). The 
mean PEP cost was $1,136/person treated (1998 US$, biologics and administration), equivalent 
to between $27,264/100,000 and $38,624/100,000 residents. This amount is notably lower than 
the amount recorded in Massachusetts (2), but New York coordinates aspects of PEP (4). 
Recently (1998–2002), when a skunk rabies epizootic spread from San Luis Obispo to 
Santa Barbara County, the direct and indirect costs due to rabies exposure in southern California 
were documented, (5). County records documented the medical and public health activities 
required of 134 patients (equivalent to 4.1/100,000 county resident-years, using 2002 population 
estimates for 5 years). The public health costs included case investigations and animal control 
expenses. Telephone interviews of 55 patients who were given PEP provided indirect patient-
related expenses related to receiving PEP (e.g., alternative medicine, daycare, travel, time lost 
from work). The mean total cost of a suspected human rabies exposure was $3,688/patient; 
average direct (biologics, medical costs) and indirect costs were $2,564/patient and 
$1,124/patient, respectively (2005 US$). 
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Wildlife Oral Rabies Vaccination,  
Canada and the United States 
Technical Appendix 2 
Correction for Inflation of Selected Costs in Original Publications 
This Technical Appendix provides selected oral rabies vaccination (ORV), point 
infection control (PIC), trap–vaccinate–release (TVR), and postexposure propylaxis (PEP) costs 
for studies cited in the article; published costs are corrected for inflation. The annual Consumer 
Price Index (CPI %) between 1990 and 2007 for “all goods and services (urban consumers)” was 
used to derive 2008 values. Bank of Canada 
(http://www.bankofcanada.ca/en/rates/inflation_calc.html) and the United States Bureau of 
Labor Statistics (http://www.bls.gov/CPI/#overview) were sources of CPI rates. 
 
Table 1. Annual Consumer Price Index inflation (% change 
between years)* 
Year Canada United States 
1990 4.8 5.4 
1991 5.6 4.2 
1992 1.4 3.0 
1993 1.9 3.0 
1994 0.1 2.6 
1995 2.2 2.8 
1996 1.5 2.9 
1997 1.7 2.3 
1998 1.0 1.6 
1999 1.8 2.2 
2000 2.7 3.4 
2001 2.5 2.8 
2002 2.2 1.6 
2003 2.8 2.3 
2004 1.8 2.7 
2005 2.2 3.4 
2006 2.0 3.2 
2007 2.2 2.8 
2008 2.3 3.8 
*Briefly, costs cited in the original publications were compounded for years 
subsequent to the originally specified oral rabies vaccination, trap–
vaccinate–release, point infection control, and postexposure prophylaxis 
cost estimates. If no monetary year was provided in the original article, we 
arbitrarily specified a likely year for the authors’ calculations based on 1–2- 
year publication lags. As of June 25, 2008, currency conversion was as 
follows: 0.98 Can$ = 1.00 US$; whereas, as of May 5, 2009 1.00 Can$ = 
1.19 US$. 
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Table 2. List of originally cited studies and inflated cost estimates for ORV, TVR, PIC, or PEP variables in 2008 Can$ or US$* 
Study and reference 
Year or assumed year of original 
monetary estimate 
Current cost 
(Can$ or US$ in 2008) 
ORV/TVR/PIC†   
 (1) No estimate No estimate 
 (2) 1990 TVR $616/km2 Can$ 
 (3) 1999 PIC $605/km2 Can$ 
ORV only $245/km2 Can$ 
 Slate (prior unpub. data)  ORV $111/km2 US$ 
 (4) 1999 ORV $198/km2 US$ 
 
 (5) 2004 ORV $48/km2 US$ 
PEP‡   
 (6) 1990 $1,874/patient US$ 
 (7) 1995 $3,356/patient US$ 
 (8) 1995 1,501/patient US$ 
 (9) 2005 $4,066/patient US$ 
*ORV, oral rabies vaccination; TVR, trap–vaccinate–release; PIC, point infection control; PEP, postexposure prophylaxis. 
†Rosatte et al. (2001), Slate (prior unpublished data), and Foroutan et al. (2002) report ORV costs for raccoons (i.e., bait densities of 50–75/km2; Sidwa et 
al. (2004) report ORV for coyote and gray fox (i.e., bait densities of 19-39/km2). 
‡Chang et al. (2002) report PEP for New York (i.e., biologics are paid by state); Shwiff et al. (2007) report both direct and indirect costs of PEP. 
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Tactics and Economics of  
Wildlife Oral Rabies Vaccination,  
Canada and the United States 
Technical Appendix 3 
Principles of an Economic Analysis of Oral Rabies Vaccination Programs 
Rabies, Oral Rabies Vaccination and Use of Benefit:cost Analyses 
There are often no human rabies cases directly related to an epizootic of terrestrial rabies. 
Thus, it is often impossible to conduct a cost-effectiveness analysis—an often-recommended 
method for public health economics studies, in which the analytic output would be cost per 
averted case of human rabies (1). Thus, published studies have used benefit:cost methods, in 
which researchers attempt to evaluate all of the benefits and costs from ORV programs in dollar 
values (1,2). The general benefit:cost equation below illustrates the basic concept: 
Net savings (costs) = value of reduced rabies-related costs –  
                                   costs of oral rabies vaccination (ORV) program. 
Where: Value of reduced rabies–related costs = (some portion of) costs of rabies 
epizootic = additional pet vaccinations + additional livestock vaccinations + pet replacements + 
livestock replacements + additional human preexposure rabies prophylaxis + additional human 
postexposure prophylaxis (PEP) + costs of treating adverse side effects of additional PEPs + 
costs of case investigations by public health units + additional laboratory tests + quarantine of 
suspected rabid animals + public educational materials + potential loss of endangered mammals 
in areas near epizootics (3). 
To date, prevention of costs of additional pet vaccinations and PEP have been the main 
economic impacts of rabies epizootics used to evaluate benefits of ORV programs (4–7). It is 
controversial to consider additional pet vaccinations as a cost of rabies epizootic (typically, 
before a rabies epizootic, vaccination rates in dogs in the United States are between 20% and 
50% (8). Experience has shown that ORV programs cannot guarantee elimination of all rabies 
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risks to pets (e.g., ORV zones have been breached, bat rabies is not controlled by current ORV 
programs). It has been argued that it is potentially a benefit, and not a cost, if pet rabies 
vaccination rates increase, regardless of cause (S.A. Shwiff, unpub. data). Also, pet replacement 
costs have never, to our knowledge, actually been measured, and there has yet to be a valuation 
of a loss of endangered species due to a rabies epizootic. 
ORV-Related Program Cost 
Costs of an ORV program (often multiyear) can be defined as follows (3–5): 
Costs of an ORV program per year = (area covered in 1 year × vaccine-bait density per 
unit area × price of individual vaccine-baits) + distribution costs + costs of injuries/ 
accidents + costs of contingency plans 
Vaccine-baits have, to date, been distributed by fixed-wing aircraft, helicopters, and 
ground (i.e., personnel either walking or driving). Although accidents and injuries associated 
with ORV operations have been rare, the potential for these costs remain and must be considered 
in any economic assessment of ORV. Injuries to employees performing baiting operations are 
typically covered by some form of preexisting insurance (i.e., costs are prepaid and thus not 
usually included), but potential public injury or death due to various events remains a possibility. 
To date, in the United States, only 1 accident involving a citizen’s exposure to the live vaccine in 
ORV baits has occurred. The citizen sued the public health agency responsible for distributing 
the baits. The court, however, ruled in favor of the public health department, incurring zero cost 
to the public (9). 
Analytic Timeline 
Rabies epizootics usually last >2 years and may exhibit cyclic patterns (i.e., number of 
rabid animals increase and decrease as the animal population changes). The costs of controlling 
rabies can be considered as having 3 different time periods: preepizootic, during epizootic, and 
postepizootic. It is possible that during the postepizootic period rabies control costs will not 
subside to preepizootic levels (1). Similarly, an ORV program will typically last >5 years. Thus, 
an economic study of ORV programs must incorporate the multiyear aspects of benefits and 
costs. 
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Perspective and Discounting 
Because a substantial part of the costs of a rabies epizootic and an ORV program are 
borne by public health entities, it is appropriate that any analyses of an ORV program take a 
societal perspective as the principal perspective. Furthermore, because rabies epizootics and 
ORV programs may each take several years, benefits and costs must be appropriately discounted 
(1,2,6). 
Units of Analysis 
The economics of ORV are determined by human population density (i.e., increased 
human population results in increased probability and numbers of PEPs, pet vaccinations, etc.). It 
has been shown that human population density can impact the number of animals tested for 
rabies (10). Thus, it is recommended that both benefits and costs of ORV programs be calculated 
in terms of $/unit area (S.A. Shwiff, unpub.data). This allows for ready comparison within a 
program over time (as populations change), comparison between programs (with possible 
differences by targeted species and locale), and consideration of targeting and prioritization (by 
economic criteria). 
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